The global market for Image-guided Injectables was valued at US$ 5764 million in the year 2024 and is projected to reach a revised size of US$ 9082 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Image-guided Injectables Market

Image-guided injectables refer to injectable drugs, biologics, or fillers administered under real-time visualization using imaging modalities such as ultrasound, CT, MRI, or fluoroscopy to ensure precise delivery to targeted tissues or lesions. These injectables are widely used in pain management, tumor ablation, regenerative medicine, nerve blockade, joint therapy, and aesthetic applications. Compared with conventional injection procedures, image-guided injectables significantly improve delivery accuracy, minimize collateral tissue damage, and enhance therapeutic outcomes. The ecosystem typically comprises imaging guidance systems, specialized needles, and tailored formulations, representing a key intersection of precision medicine and interventional therapeutics.The average gross profit margin of this product is 55%.

The growth of the image-guided injectables market is propelled by the convergence of precision medicine and minimally invasive intervention technologies. The widespread adoption of ultrasound and MRI guidance has expanded applications in orthopedics, neurology, and regenerative therapies, particularly for chronic pain, joint disorders, and localized tumor management. The increasing demand for personalized, precision-based drug delivery and advancements in high-resolution imaging and smart needle guidance systems have opened new frontiers for innovation. The integration of regenerative injectables with targeted drug delivery further positions this field as a viable alternative to surgical interventions.

Despite promising prospects, commercialization faces multiple barriers. High imaging system costs and procedural complexity limit accessibility in smaller healthcare settings. Ensuring the chemical stability and accuracy of drug delivery under guided conditions imposes stringent formulation requirements. Radiation exposure, operator training, and multidisciplinary integration further elevate technical entry barriers. Moreover, lengthy regulatory processes and biocompatibility validation challenges extend the development timelines for innovative image-guided injectable products.

Demand is shifting toward highly precise and personalized therapeutic applications. Ultrasound-guided injections are expanding in orthopedics and neurology, while dermatology and aesthetic sectors adopt image navigation for improved safety and consistency. Oncology, interventional radiology, and regenerative medicine centers increasingly utilize image-guided delivery for localized drug targeting. Aging populations and rising chronic disease prevalence drive the adoption of precision injection therapies, transforming conventional drug delivery into intelligent, image-integrated systems.

The upstream ecosystem encompasses active pharmaceutical ingredients, biological carriers, contrast or visualization agents, and imaging-compatible delivery tools. Injectable formulations rely on high-purity biomolecules such as peptides and extracellular matrix proteins, while contrast materials require a balance of imaging sensitivity and biocompatibility. Delivery needles and catheters prioritize flexibility, navigational precision, and contamination control. Variations in material cost and technological sophistication directly impact pricing and scalability. The advancement of MRI-compatible materials and smart-guidance tools is expected to drive greater standardization and automation in the upstream supply chain.

This report aims to provide a comprehensive presentation of the global market for Image-guided Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Image-guided Injectables.

The Image-guided Injectables market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Image-guided Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, by Clinical Application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Image-guided Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Image-guided Injectables Market Report

Report Metric	Details
Report Name	Image-guided Injectables Market
Accounted market size in year	US$ 5764 million
Forecasted market size in 2031	US$ 9082 million
CAGR	6.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Ultrasound-Guided Fluoro /CT-Guided Endoscopic/EUS-Guided MRI-Guided
Segment by Clinical Application	Orthopedics & MSK Tumor Ablation Regenerative Medicine Nerve Block Other
Segment by Injectable Type	Pharmaceutical Injectables Biologic Injectables Filler-based Injectables Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boston Scientific, Terumo, BD Medical, Merit Medical, Teleflex, Cook Medical, B. Braun, Stryker, AngioDynamics, Hologic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Clinical Application etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Image-guided Injectables company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Image-guided Injectables Market growing?

Ans: The Image-guided Injectables Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Image-guided Injectables Market size in 2031?

Ans: The Image-guided Injectables Market size in 2031 will be US$ 9082 million.

Who are the main players in the Image-guided Injectables Market report?

Ans: The main players in the Image-guided Injectables Market are Boston Scientific, Terumo, BD Medical, Merit Medical, Teleflex, Cook Medical, B. Braun, Stryker, AngioDynamics, Hologic

What are the Application segmentation covered in the Image-guided Injectables Market report?

Ans: The Applications covered in the Image-guided Injectables Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Image-guided Injectables Market report?

Ans: The Types covered in the Image-guided Injectables Market report are Pharmaceutical Injectables, Biologic Injectables, Filler-based Injectables, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Image-guided Injectables Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Ultrasound-Guided

1.2.3 Fluoro /CT-Guided

1.2.4 Endoscopic/EUS-Guided

1.2.5 MRI-Guided

1.3 Market by Clinical Application

1.3.1 Global Image-guided Injectables Market Size Growth Rate by Clinical Application: 2020 VS 2024 VS 2031

1.3.2 Orthopedics & MSK

1.3.3 Tumor Ablation

1.3.4 Regenerative Medicine

1.3.5 Nerve Block

1.3.6 Other

1.4 Market by Injectable Type

1.4.1 Global Image-guided Injectables Market Size Growth Rate by Injectable Type: 2020 VS 2024 VS 2031

1.4.2 Pharmaceutical Injectables

1.4.3 Biologic Injectables

1.4.4 Filler-based Injectables

1.4.5 Other

1.5 Market by Application

1.5.1 Global Image-guided Injectables Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Image-guided Injectables Market Perspective (2020-2031)

2.2 Global Image-guided Injectables Growth Trends by Region

2.2.1 Global Image-guided Injectables Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Image-guided Injectables Historic Market Size by Region (2020-2025)

2.2.3 Image-guided Injectables Forecasted Market Size by Region (2026-2031)

2.3 Image-guided Injectables Market Dynamics

2.3.1 Image-guided Injectables Industry Trends

2.3.2 Image-guided Injectables Market Drivers

2.3.3 Image-guided Injectables Market Challenges

2.3.4 Image-guided Injectables Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Image-guided Injectables Players by Revenue

3.1.1 Global Top Image-guided Injectables Players by Revenue (2020-2025)

3.1.2 Global Image-guided Injectables Revenue Market Share by Players (2020-2025)

3.2 Global Top Image-guided Injectables Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Image-guided Injectables Revenue

3.4 Global Image-guided Injectables Market Concentration Ratio

3.4.1 Global Image-guided Injectables Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Image-guided Injectables Revenue in 2024

3.5 Global Key Players of Image-guided Injectables Head office and Area Served

3.6 Global Key Players of Image-guided Injectables, Product and Application

3.7 Global Key Players of Image-guided Injectables, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Image-guided Injectables Breakdown Data by Type

4.1 Global Image-guided Injectables Historic Market Size by Type (2020-2025)

4.2 Global Image-guided Injectables Forecasted Market Size by Type (2026-2031)

5 Image-guided Injectables Breakdown Data by Application

5.1 Global Image-guided Injectables Historic Market Size by Application (2020-2025)

5.2 Global Image-guided Injectables Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Image-guided Injectables Market Size (2020-2031)

6.2 North America Image-guided Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Image-guided Injectables Market Size by Country (2020-2025)

6.4 North America Image-guided Injectables Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Image-guided Injectables Market Size (2020-2031)

7.2 Europe Image-guided Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Image-guided Injectables Market Size by Country (2020-2025)

7.4 Europe Image-guided Injectables Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Image-guided Injectables Market Size (2020-2031)

8.2 Asia-Pacific Image-guided Injectables Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Image-guided Injectables Market Size by Region (2020-2025)

8.4 Asia-Pacific Image-guided Injectables Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Image-guided Injectables Market Size (2020-2031)

9.2 Latin America Image-guided Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Image-guided Injectables Market Size by Country (2020-2025)

9.4 Latin America Image-guided Injectables Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Image-guided Injectables Market Size (2020-2031)

10.2 Middle East & Africa Image-guided Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Image-guided Injectables Market Size by Country (2020-2025)

10.4 Middle East & Africa Image-guided Injectables Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Boston Scientific

11.1.1 Boston Scientific Company Details

11.1.2 Boston Scientific Business Overview

11.1.3 Boston Scientific Image-guided Injectables Introduction

11.1.4 Boston Scientific Revenue in Image-guided Injectables Business (2020-2025)

11.1.5 Boston Scientific Recent Development

11.2 Terumo

11.2.1 Terumo Company Details

11.2.2 Terumo Business Overview

11.2.3 Terumo Image-guided Injectables Introduction

11.2.4 Terumo Revenue in Image-guided Injectables Business (2020-2025)

11.2.5 Terumo Recent Development

11.3 BD Medical

11.3.1 BD Medical Company Details

11.3.2 BD Medical Business Overview

11.3.3 BD Medical Image-guided Injectables Introduction

11.3.4 BD Medical Revenue in Image-guided Injectables Business (2020-2025)

11.3.5 BD Medical Recent Development

11.4 Merit Medical

11.4.1 Merit Medical Company Details

11.4.2 Merit Medical Business Overview

11.4.3 Merit Medical Image-guided Injectables Introduction

11.4.4 Merit Medical Revenue in Image-guided Injectables Business (2020-2025)

11.4.5 Merit Medical Recent Development

11.5 Teleflex

11.5.1 Teleflex Company Details

11.5.2 Teleflex Business Overview

11.5.3 Teleflex Image-guided Injectables Introduction

11.5.4 Teleflex Revenue in Image-guided Injectables Business (2020-2025)

11.5.5 Teleflex Recent Development

11.6 Cook Medical

11.6.1 Cook Medical Company Details

11.6.2 Cook Medical Business Overview

11.6.3 Cook Medical Image-guided Injectables Introduction

11.6.4 Cook Medical Revenue in Image-guided Injectables Business (2020-2025)

11.6.5 Cook Medical Recent Development

11.7 B. Braun

11.7.1 B. Braun Company Details

11.7.2 B. Braun Business Overview

11.7.3 B. Braun Image-guided Injectables Introduction

11.7.4 B. Braun Revenue in Image-guided Injectables Business (2020-2025)

11.7.5 B. Braun Recent Development

11.8 Stryker

11.8.1 Stryker Company Details

11.8.2 Stryker Business Overview

11.8.3 Stryker Image-guided Injectables Introduction

11.8.4 Stryker Revenue in Image-guided Injectables Business (2020-2025)

11.8.5 Stryker Recent Development

11.9 AngioDynamics

11.9.1 AngioDynamics Company Details

11.9.2 AngioDynamics Business Overview

11.9.3 AngioDynamics Image-guided Injectables Introduction

11.9.4 AngioDynamics Revenue in Image-guided Injectables Business (2020-2025)

11.9.5 AngioDynamics Recent Development

11.10 Hologic

11.10.1 Hologic Company Details

11.10.2 Hologic Business Overview

11.10.3 Hologic Image-guided Injectables Introduction

11.10.4 Hologic Revenue in Image-guided Injectables Business (2020-2025)

11.10.5 Hologic Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Image-guided Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Ultrasound-Guided

Table 3. Key Players of Fluoro /CT-Guided

Table 4. Key Players of Endoscopic/EUS-Guided

Table 5. Key Players of MRI-Guided

Table 6. Global Image-guided Injectables Market Size Growth Rate by Clinical Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Orthopedics & MSK

Table 8. Key Players of Tumor Ablation

Table 9. Key Players of Regenerative Medicine

Table 10. Key Players of Nerve Block

Table 11. Key Players of Other

Table 12. Global Image-guided Injectables Market Size Growth Rate by Injectable Type (US$ Million): 2020 VS 2024 VS 2031

Table 13. Key Players of Pharmaceutical Injectables

Table 14. Key Players of Biologic Injectables

Table 15. Key Players of Filler-based Injectables

Table 16. Key Players of Other

Table 17. Global Image-guided Injectables Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Image-guided Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Image-guided Injectables Market Size by Region (2020-2025) & (US$ Million)

Table 20. Global Image-guided Injectables Market Share by Region (2020-2025)

Table 21. Global Image-guided Injectables Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 22. Global Image-guided Injectables Market Share by Region (2026-2031)

Table 23. Image-guided Injectables Market Trends

Table 24. Image-guided Injectables Market Drivers

Table 25. Image-guided Injectables Market Challenges

Table 26. Image-guided Injectables Market Restraints

Table 27. Global Image-guided Injectables Revenue by Players (2020-2025) & (US$ Million)

Table 28. Global Image-guided Injectables Market Share by Players (2020-2025)

Table 29. Global Top Image-guided Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Image-guided Injectables as of 2024)

Table 30. Ranking of Global Top Image-guided Injectables Companies by Revenue (US$ Million) in 2024

Table 31. Global 5 Largest Players Market Share by Image-guided Injectables Revenue (CR5 and HHI) & (2020-2025)

Table 32. Global Key Players of Image-guided Injectables, Headquarters and Area Served

Table 33. Global Key Players of Image-guided Injectables, Product and Application

Table 34. Global Key Players of Image-guided Injectables, Date of Enter into This Industry

Table 35. Mergers & Acquisitions, Expansion Plans

Table 36. Global Image-guided Injectables Market Size by Type (2020-2025) & (US$ Million)

Table 37. Global Image-guided Injectables Revenue Market Share by Type (2020-2025)

Table 38. Global Image-guided Injectables Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 39. Global Image-guided Injectables Revenue Market Share by Type (2026-2031)

Table 40. Global Image-guided Injectables Market Size by Application (2020-2025) & (US$ Million)

Table 41. Global Image-guided Injectables Revenue Market Share by Application (2020-2025)

Table 42. Global Image-guided Injectables Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 43. Global Image-guided Injectables Revenue Market Share by Application (2026-2031)

Table 44. North America Image-guided Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. North America Image-guided Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 46. North America Image-guided Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 47. Europe Image-guided Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Europe Image-guided Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 49. Europe Image-guided Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 50. Asia-Pacific Image-guided Injectables Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 51. Asia-Pacific Image-guided Injectables Market Size by Region (2020-2025) & (US$ Million)

Table 52. Asia-Pacific Image-guided Injectables Market Size by Region (2026-2031) & (US$ Million)

Table 53. Latin America Image-guided Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 54. Latin America Image-guided Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 55. Latin America Image-guided Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 56. Middle East & Africa Image-guided Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 57. Middle East & Africa Image-guided Injectables Market Size by Country (2020-2025) & (US$ Million)

Table 58. Middle East & Africa Image-guided Injectables Market Size by Country (2026-2031) & (US$ Million)

Table 59. Boston Scientific Company Details

Table 60. Boston Scientific Business Overview

Table 61. Boston Scientific Image-guided Injectables Product

Table 62. Boston Scientific Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 63. Boston Scientific Recent Development

Table 64. Terumo Company Details

Table 65. Terumo Business Overview

Table 66. Terumo Image-guided Injectables Product

Table 67. Terumo Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 68. Terumo Recent Development

Table 69. BD Medical Company Details

Table 70. BD Medical Business Overview

Table 71. BD Medical Image-guided Injectables Product

Table 72. BD Medical Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 73. BD Medical Recent Development

Table 74. Merit Medical Company Details

Table 75. Merit Medical Business Overview

Table 76. Merit Medical Image-guided Injectables Product

Table 77. Merit Medical Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 78. Merit Medical Recent Development

Table 79. Teleflex Company Details

Table 80. Teleflex Business Overview

Table 81. Teleflex Image-guided Injectables Product

Table 82. Teleflex Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 83. Teleflex Recent Development

Table 84. Cook Medical Company Details

Table 85. Cook Medical Business Overview

Table 86. Cook Medical Image-guided Injectables Product

Table 87. Cook Medical Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 88. Cook Medical Recent Development

Table 89. B. Braun Company Details

Table 90. B. Braun Business Overview

Table 91. B. Braun Image-guided Injectables Product

Table 92. B. Braun Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 93. B. Braun Recent Development

Table 94. Stryker Company Details

Table 95. Stryker Business Overview

Table 96. Stryker Image-guided Injectables Product

Table 97. Stryker Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 98. Stryker Recent Development

Table 99. AngioDynamics Company Details

Table 100. AngioDynamics Business Overview

Table 101. AngioDynamics Image-guided Injectables Product

Table 102. AngioDynamics Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 103. AngioDynamics Recent Development

Table 104. Hologic Company Details

Table 105. Hologic Business Overview

Table 106. Hologic Image-guided Injectables Product

Table 107. Hologic Revenue in Image-guided Injectables Business (2020-2025) & (US$ Million)

Table 108. Hologic Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Image-guided Injectables Picture

Figure 2. Global Image-guided Injectables Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Image-guided Injectables Market Share by Type: 2024 VS 2031

Figure 4. Ultrasound-Guided Features

Figure 5. Fluoro /CT-Guided Features

Figure 6. Endoscopic/EUS-Guided Features

Figure 7. MRI-Guided Features

Figure 8. Global Image-guided Injectables Market Size Comparison by Clinical Application (2020-2031) & (US$ Million)

Figure 9. Orthopedics & MSK Features

Figure 10. Tumor Ablation Features

Figure 11. Regenerative Medicine Features

Figure 12. Nerve Block Features

Figure 13. Other Features

Figure 14. Global Image-guided Injectables Market Size Comparison by Injectable Type (2020-2031) & (US$ Million)

Figure 15. Pharmaceutical Injectables Features

Figure 16. Biologic Injectables Features

Figure 17. Filler-based Injectables Features

Figure 18. Other Features

Figure 19. Global Image-guided Injectables Market Size by Application (2020-2031) & (US$ Million)

Figure 20. Global Image-guided Injectables Market Share by Application: 2024 VS 2031

Figure 21. Hospital Case Studies

Figure 22. Clinic Case Studies

Figure 23. Other Case Studies

Figure 24. Image-guided Injectables Report Years Considered

Figure 25. Global Image-guided Injectables Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 26. Global Image-guided Injectables Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 27. Global Image-guided Injectables Market Share by Region: 2024 VS 2031

Figure 28. Global Image-guided Injectables Market Share by Players in 2024

Figure 29. Global Image-guided Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 30. The Top 10 and 5 Players Market Share by Image-guided Injectables Revenue in 2024

Figure 31. North America Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. North America Image-guided Injectables Market Share by Country (2020-2031)

Figure 33. United States Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Canada Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Europe Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Europe Image-guided Injectables Market Share by Country (2020-2031)

Figure 37. Germany Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. France Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. U.K. Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Italy Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Russia Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Ireland Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Asia-Pacific Image-guided Injectables Market Share by Region (2020-2031)

Figure 45. China Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Japan Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. South Korea Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Southeast Asia Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. India Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Australia & New Zealand Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Latin America Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Latin America Image-guided Injectables Market Share by Country (2020-2031)

Figure 53. Mexico Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Brazil Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Middle East & Africa Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Middle East & Africa Image-guided Injectables Market Share by Country (2020-2031)

Figure 57. Israel Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. UAE Image-guided Injectables Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 60. Boston Scientific Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 61. Terumo Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 62. BD Medical Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 63. Merit Medical Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 64. Teleflex Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 65. Cook Medical Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 66. B. Braun Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 67. Stryker Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 68. AngioDynamics Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 69. Hologic Revenue Growth Rate in Image-guided Injectables Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions